471 related articles for article (PubMed ID: 19366986)
1. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
Sharma MD; Hou DY; Liu Y; Koni PA; Metz R; Chandler P; Mellor AL; He Y; Munn DH
Blood; 2009 Jun; 113(24):6102-11. PubMed ID: 19366986
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
[TBL] [Abstract][Full Text] [Related]
3. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
Baban B; Chandler PR; Sharma MD; Pihkala J; Koni PA; Munn DH; Mellor AL
J Immunol; 2009 Aug; 183(4):2475-83. PubMed ID: 19635913
[TBL] [Abstract][Full Text] [Related]
4. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.
Munn DH; Sharma MD; Hou D; Baban B; Lee JR; Antonia SJ; Messina JL; Chandler P; Koni PA; Mellor AL
J Clin Invest; 2004 Jul; 114(2):280-90. PubMed ID: 15254595
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Syncytial Virus Infection Reduces Kynurenic Acid Production and Reverses Th17/Treg Balance by Modulating Indoleamine 2,3-Dioxygenase (IDO) Molecules in Plasmacytoid Dendritic Cells.
Jin L; Hu Q; Hu Y; Chen Z; Liao W
Med Sci Monit; 2020 Dec; 26():e926763. PubMed ID: 33262321
[TBL] [Abstract][Full Text] [Related]
6. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
Lippens C; Duraes FV; Dubrot J; Brighouse D; Lacroix M; Irla M; Aubry-Lachainaye JP; Reith W; Mandl JN; Hugues S
J Autoimmun; 2016 Dec; 75():39-49. PubMed ID: 27470005
[TBL] [Abstract][Full Text] [Related]
7. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.
Sharma MD; Hou DY; Baban B; Koni PA; He Y; Chandler PR; Blazar BR; Mellor AL; Munn DH
Immunity; 2010 Dec; 33(6):942-54. PubMed ID: 21145762
[TBL] [Abstract][Full Text] [Related]
8. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.
Chenna Narendra S; Chalise JP; Biggs S; Kalinke U; Magnusson M
Front Immunol; 2018; 9():285. PubMed ID: 29515584
[TBL] [Abstract][Full Text] [Related]
10. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
Ou X; Cai S; Liu P; Zeng J; He Y; Wu X; Du J
J Cancer Res Clin Oncol; 2008 May; 134(5):525-33. PubMed ID: 17909857
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
[TBL] [Abstract][Full Text] [Related]
14. p-Coumaric acid inhibits indoleamine 2, 3-dioxygenase expression in murine dendritic cells.
Kim SI; Jeong YI; Jung ID; Lee JS; Lee CM; Yoon MS; Seong EY; Kim JI; Lee JD; Park YM
Int Immunopharmacol; 2007 Jun; 7(6):805-15. PubMed ID: 17466914
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase, Tregs and cancer.
Munn DH
Curr Med Chem; 2011; 18(15):2240-6. PubMed ID: 21517755
[TBL] [Abstract][Full Text] [Related]
16. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
17. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract][Full Text] [Related]
19. Physiologic control of IDO competence in splenic dendritic cells.
Baban B; Chandler PR; Johnson BA; Huang L; Li M; Sharpe ML; Francisco LM; Sharpe AH; Blazar BR; Munn DH; Mellor AL
J Immunol; 2011 Sep; 187(5):2329-35. PubMed ID: 21813777
[TBL] [Abstract][Full Text] [Related]
20. 1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of Tregs.
Li Y; Xu J; Zou H; Wang C
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):344-8. PubMed ID: 20556579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
